CD19×CD3 bispecific T cell engager treatment induces remission in experimental pemphigoid disease
Molecular Therapy Advances
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
CD19×CD3 bispecific T cell engager treatment induces remission in experimental pemphigoid disease. // Molecular Therapy Advances. – URL: https://www.sciencedirect.com/science/article/pii/S3117387X26001606?dgcid=rss_sd_all
CD19×CD3 bispecific T cell engager treatment induces remission in experimental pemphigoid disease. Molecular Therapy Advances. https://www.sciencedirect.com/science/article/pii/S3117387X26001606?dgcid=rss_sd_all
“CD19×CD3 bispecific T cell engager treatment induces remission in experimental pemphigoid disease.” Molecular Therapy Advances.
@article{article117403,
title = {CD19×CD3 bispecific T cell engager treatment induces remission in experimental pemphigoid disease},
journal = {Molecular Therapy Advances},
url = {https://www.sciencedirect.com/science/article/pii/S3117387X26001606?dgcid=rss_sd_all}
}